BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1101938)

  • 1. Leukaemic conversion of non-Hodgkin's malignant lymphomata.
    Mathé G; Pouillart P; Schwarzenberg L; Hayat M; Amiel JL; Schlumberger JR; Misset J; Musset M; Jasmin C; De Vassal F
    Br J Cancer Suppl; 1975 Mar; 2():96-101. PubMed ID: 1101938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary results of an immunotherapy trial on terminal leukaemic lymphosarcoma.
    Mathé G; Belpomme D; Pouillart P; Schwarzenberg L; Misset JL; Jasmin MC; Musset M; Cattan A; Amiel JL; Schneider M
    Biomedicine; 1975 Dec; 23(10):465-7. PubMed ID: 1063043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Hodgkin's lymphoma in children.
    Pinkel D; Johnson W; Aur RJ
    Br J Cancer Suppl; 1975 Mar; 2():298-323. PubMed ID: 1101924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Leukemic transformation of non-hodgkinian hematosarcomas (lymphomas). Efficacity of immunotherapy].
    Mathé G; Pouillart P; Schwarzenberg L; Hayat M; Amiel JL; Schlumberger JR; De Vassal F
    Bull Cancer; 1974; 61(1):69-78. PubMed ID: 4617612
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytology in the classification of diffuse non-leukaemic malignant lymphomata (lympho- and reticulosarcomata).
    Mathé G; Pouillart P; Schlumberger JR; Paintrand M
    Br J Cancer Suppl; 1975 Mar; 2():53-9. PubMed ID: 1101935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
    Mathé G; Belpomme D; Dantchev D; Pouillart P
    Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress made in the classification of lymphoid and monocytoid leukemias and of lympho- and reticulo-sarcomas].
    Mathe G; Belpomme D; Dantchev D; Pouillart P
    Ann Med Interne (Paris); 1975; 126(8-9):523-34. PubMed ID: 766687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New experimental and clinical data on leukaemia immunotherapy.
    Mathé G; Schwarzenberg L; Amiel JL; Pouillart P; Hayat M; de Vassal F; Rosenfeld C; Jasmin C
    Proc R Soc Med; 1975 Apr; 68(4):211-6. PubMed ID: 1060146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningosis-prophylaxis in the treatment of acute lymphoblastic leukemia and of non-Hodgkin's lymphomas (author's transl)].
    Wehinger H
    Strahlentherapie; 1977 Apr; 153(4):236-40. PubMed ID: 266295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinico-pathological study of non-Hodgkin's lymphomata in childhood.
    Landberg T; Garwicz S; Akerman M
    Br J Cancer Suppl; 1975 Mar; 2():332-6. PubMed ID: 1101926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse histiocytic lymphoma after histologic conversion: a poor prognostic variant.
    Armitage JO; Dick FR; Corder MP
    Cancer Treat Rep; 1981; 65(5-6):413-8. PubMed ID: 7016324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease.
    Armitage JO; Dick FR; Goeken JA; Foucar MK; Gingrich RD
    Arch Intern Med; 1983 Mar; 143(3):445-50. PubMed ID: 6338848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CEOP regimen in the treatment for non-Hodgkin's lymphoma].
    Huang HQ; Lin XB; Pan ZH; Bu Q; Gao Y; Wang BF; Cai QQ; Xia ZJ; Xu RH; Jiang WQ; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinico-morphological parallels in prolymphocytic type leukemic transformation of lymphosarcoma].
    Lorie IuI; Solov'eva EA; Kruglova GV
    Probl Gematol Pereliv Krovi; 1975 Oct; 20(10):4-8. PubMed ID: 1242805
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukaemic progression in lymphomata.
    Kroese WF; Cleton FJ; Somers R
    Br J Cancer Suppl; 1975 Mar; 2():102-6. PubMed ID: 170950
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
    Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-Hodgkin's lymphoma of the thyroid gland--2 case reports].
    Milosević R; Antonijević N; Mihaljević B; Milivojević G; Petrović M; Jovanović V; Colović M
    Srp Arh Celok Lek; 1996; 124(11-12):318-20. PubMed ID: 9132968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas].
    Osmanov DSh; Kruglova GV; Frenkel' MA; Tupitsin NN; Probatova NA; Kondrat'eva TT; Sholokhova EN; Finogenova IA; Dvoretskiĭ VV
    Ter Arkh; 1996; 68(7):42-8. PubMed ID: 8928071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.